Future of Pharmaceuticals for Human Use in Europe
Name: Consultation on the Future of Pharmaceuticals for Human Use in EuropeSource: European Commission
Date: October 2007
Overall Cancer Research UK agrees with the challenges facing the EU pharmaceutical sector as outlined in the European Commission’s consultation document. In our view the EU regulatory framework is a central issue affecting organisations such as Cancer Research UK who are involved in the development of pharmaceuticals.
We support necessary legislation relating to the development, marketing and selling of pharmaceuticals. However, Cancer Research UK has some suggestions on the bureaucracy and coherence involved with clinical trials legislation.
For instance while we believe that the EU Clinical Trials Directive has been successful in improving the design of trials, the way in which such legislation is interpreted differently by Member States leads to ambiguity and is not conducive to supporting research.
For more information, please read the consultation response in full.
